NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today that it held a …
[Read more...] about Celsus Therapeutics Provides Update on MRX-6 from FDA Pre-IND Meeting
Celsus Therapeutics Plc to Present at the 2014 BIO CEO & Investor Conference
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today that Dr. Gur Roshwalb, Chief …
[Read more...] about Celsus Therapeutics Plc to Present at the 2014 BIO CEO & Investor Conference
Celsus Therapeutics Announces the Closing of $9.2 Million Public Offering and Full Exercise of Underwriters Option to Purchase Additional ADSs
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today the closing of its previously …
Celsus Therapeutics Announces Pricing of Public Offering and Listing on NASDAQ
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX)(formerly OTCQB:CLSXD), an emerging growth, development-stage biotech company, announced today the …
[Read more...] about Celsus Therapeutics Announces Pricing of Public Offering and Listing on NASDAQ
Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer
NEW YORK AND LONDON Celsus Therapeutics (OTCQB: CLSXY), an emerging growth, development-stage biopharmaceutical company, announces the appointment of Pablo …
